Trials / Completed
CompletedNCT01244022
Cytokine Changes After Colorectal Cancer Resection
Postoperative Serum Cytokine Changes After Radical Resection of Colorectal Cancer
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 28 (actual)
- Sponsor
- University Hospital Dubrava · Academic / Other
- Sex
- All
- Age
- 20 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
Based on our previous research, this study aims to determine reliable surgical stress response markers in patients undergoing radical resection of colorectal cancer.
Detailed description
Every surgical intervention represents a stress for patient's organism. During the operation, numerous changes in the patient's metabolism take place, that are termed surgical stress response. Leading cause of surgical stress response is tissue destruction that always accompanies operations. Surgical stress response is effected through activation of hypothalamus-pituitary-adrenal axis and through sympathetic activation. The consequences of surgical stress response are numerous. Surgical stress response is essential to uneventful postoperative recovery. On the other hand, excessive surgical stress response may lead to serious postoperative complications, such as heart and kidney failure, venous thrombosis, disruption of operative wound and wound infection. In prior studies the investigators have shown the kinetics of postoperative serum interleukin changes after radical resection of gastric cancer. This study aims at determining reliable markers of surgical stress response severity in patients undergoing radical resection of colorectal cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | colorectal cancer resection | Open radical resection of colorectal cancer, according to oncological principals, depending on the tumor site |
Timeline
- Start date
- 2010-08-01
- Primary completion
- 2012-12-01
- Completion
- 2012-12-01
- First posted
- 2010-11-19
- Last updated
- 2013-07-16
Locations
1 site across 1 country: Croatia
Source: ClinicalTrials.gov record NCT01244022. Inclusion in this directory is not an endorsement.